Staphylococcus Aureus Septicemia: Clinical Trials

1 trial for Staphylococcus Aureus Septicemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Staphylococcus Aureus Septicemia: new trials by email Literature Review of Staphylococcus Aureus Septicemia trials Research Report on Staphylococcus Aureus Septicemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Ertapenem, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia
Phase 2RecruitingTodd C. Lee MD MPH FIDSA602024-05-202026-11-02

Narrower conditions

Bacteremia (1)  ·  Staphylococcal Infections (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Ertapenem (1)

Sponsors

Todd C. Lee MD MPH FIDSA (1)

Countries

Canada (1)

Top investigators

Emily G McDonald, MD MSc (1)  ·  Matthew P Cheng, MD (1)  ·  Todd C Lee, MD MPH FIDSA (1)

Results publications

PMID 41433510